662 related articles for article (PubMed ID: 30901218)
1. Biodegradable and pH-Responsive Acetalated Dextran (Ac-Dex) Nanoparticles for NIR Imaging and Controlled Delivery of a Platinum-Based Prodrug into Cancer Cells.
Braga CB; Perli G; Becher TB; Ornelas C
Mol Pharm; 2019 May; 16(5):2083-2094. PubMed ID: 30901218
[TBL] [Abstract][Full Text] [Related]
2. Enhancing the Anticancer Activity and Selectivity of Goniothalamin Using pH-Sensitive Acetalated Dextran (Ac-Dex) Nanoparticles: A Promising Platform for Delivery of Natural Compounds.
Braga CB; Kido LA; Lima EN; Lamas CA; Cagnon VHA; Ornelas C; Pilli RA
ACS Biomater Sci Eng; 2020 May; 6(5):2929-2942. PubMed ID: 33463303
[TBL] [Abstract][Full Text] [Related]
3. Platinum(IV) prodrug conjugated Pd@Au nanoplates for chemotherapy and photothermal therapy.
Shi S; Chen X; Wei J; Huang Y; Weng J; Zheng N
Nanoscale; 2016 Mar; 8(10):5706-13. PubMed ID: 26900670
[TBL] [Abstract][Full Text] [Related]
4. Gelatin-encapsulated iron oxide nanoparticles for platinum (IV) prodrug delivery, enzyme-stimulated release and MRI.
Cheng Z; Dai Y; Kang X; Li C; Huang S; Lian H; Hou Z; Ma P; Lin J
Biomaterials; 2014 Aug; 35(24):6359-68. PubMed ID: 24816364
[TBL] [Abstract][Full Text] [Related]
5. Folate-decorated and NIR-activated nanoparticles based on platinum(IV) prodrugs for targeted therapy of ovarian cancer.
Sun Y; Shi T; Zhou L; Zhou Y; Sun B; Liu X
J Microencapsul; 2017 Nov; 34(7):675-686. PubMed ID: 29027828
[TBL] [Abstract][Full Text] [Related]
6. Dextran-doxorubicin prodrug nanoparticles conjugated with CD147 monoclonal antibody for targeted drug delivery in hepatoma therapy.
Tian H; Yu L; Zhang M; He J; Sun X; Ni P
Colloids Surf B Biointerfaces; 2023 Aug; 228():113400. PubMed ID: 37331192
[TBL] [Abstract][Full Text] [Related]
7. Reduction stimuli-responsive unimolecular polymeric prodrug based on amphiphilic dextran-framework for antitumor drug delivery.
Bai S; Gao YE; Ma X; Shi X; Hou M; Xue P; Kang Y; Xu Z
Carbohydr Polym; 2018 Feb; 182():235-244. PubMed ID: 29279120
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles.
Dhar S; Gu FX; Langer R; Farokhzad OC; Lippard SJ
Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17356-61. PubMed ID: 18978032
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin Prodrug-Loaded Nanoparticles Based on Physalis Mottle Virus for Cancer Therapy.
Hu H; Steinmetz NF
Mol Pharm; 2020 Dec; 17(12):4629-4636. PubMed ID: 33186039
[TBL] [Abstract][Full Text] [Related]
10. Boronate-dextran: an acid-responsive biodegradable polymer for drug delivery.
Li L; Bai Z; Levkin PA
Biomaterials; 2013 Nov; 34(33):8504-10. PubMed ID: 23932249
[TBL] [Abstract][Full Text] [Related]
11. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
[TBL] [Abstract][Full Text] [Related]
12. Development and physicochemical characterization of acetalated dextran aerosol particle systems for deep lung delivery.
Wang Z; Gupta SK; Meenach SA
Int J Pharm; 2017 Jun; 525(1):264-274. PubMed ID: 28450166
[TBL] [Abstract][Full Text] [Related]
13. Amphiphilic polyelectrolyte/prodrug nanoparticles constructed by synergetic electrostatic and hydrophobic interactions with cooperative pH-sensitivity for controlled doxorubicin delivery.
Huang P; Wang W; Zhou J; Zhao F; Zhang Y; Liu J; Liu J; Dong A; Kong D; Zhang J
ACS Appl Mater Interfaces; 2015 Mar; 7(11):6340-50. PubMed ID: 25746122
[TBL] [Abstract][Full Text] [Related]
14. Carboplatin prodrug conjugated Fe
Song H; Quan F; Yu Z; Zheng M; Ma Y; Xiao H; Ding F
J Mater Chem B; 2019 Jan; 7(3):433-442. PubMed ID: 32254730
[TBL] [Abstract][Full Text] [Related]
15. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
Hou L; Shan X; Hao L; Feng Q; Zhang Z
Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
[TBL] [Abstract][Full Text] [Related]
16. An upconversion nanoplatform for simultaneous photodynamic therapy and Pt chemotherapy to combat cisplatin resistance.
Ai F; Sun T; Xu Z; Wang Z; Kong W; To MW; Wang F; Zhu G
Dalton Trans; 2016 Aug; 45(33):13052-60. PubMed ID: 27430044
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of acetalated dextran polymer and microparticles with ethanol as a degradation product.
Kauffman KJ; Do C; Sharma S; Gallovic MD; Bachelder EM; Ainslie KM
ACS Appl Mater Interfaces; 2012 Aug; 4(8):4149-55. PubMed ID: 22833690
[TBL] [Abstract][Full Text] [Related]
18. Targeted and NIR light-controlled delivery of nitric oxide combined with a platinum(iv) prodrug for enhanced anticancer therapy.
Shi SW; Li YH; Zhang QL; Yang SP; Liu JG
J Mater Chem B; 2019 Mar; 7(11):1867-1874. PubMed ID: 32255049
[TBL] [Abstract][Full Text] [Related]
19. Acetalated dextran based nano- and microparticles: synthesis, fabrication, and therapeutic applications.
Wang S; Fontana F; Shahbazi MA; Santos HA
Chem Commun (Camb); 2021 Apr; 57(35):4212-4229. PubMed ID: 33913978
[TBL] [Abstract][Full Text] [Related]
20. Precisely Assembled Nanoparticles against Cisplatin Resistance via Cancer-Specific Targeting of Mitochondria and Imaging-Guided Chemo-Photothermal Therapy.
Yang GG; Pan ZY; Zhang DY; Cao Q; Ji LN; Mao ZW
ACS Appl Mater Interfaces; 2020 Sep; 12(39):43444-43455. PubMed ID: 32883070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
